Product Information
MULTIVIT-FLUOR-IRON 0.25 MG/ML is a generic product labeled by Method Pharmaceuticals LLC, priced at $0.1938 per ML under NDC 58657032750. Its NADAC has been published 469 times since May 10, 2017.
MULTIVIT-FLUOR-IRON 0.25 MG/ML
VITAMIN A, ASCORBIC ACID, CHOLECALCIFEROL, ALPHA-TOCOPHEROL ACETATE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5-PHOSPHATE SODIUM, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, Ferrous sulfate and SODIUM FLUORIDEStrength
5; 35; 400; 10; 8; .4; .6; .25; .5; 1500 [iU]/mL; mg/mL; [iU]/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; [iU]/mL
Manufacturer
Method Pharmaceuticals LLCNDC
58657032750
Classification
Generic
Dosage Form
LIQUID
Route
ORAL
Effective Date
9/23/2026
Approval Type
Unapproved
On Market Since
2/24/2017
Pharmacological Classes
Price Statistics
The NADAC for MULTIVIT-FLUOR-IRON 0.25 MG/ML has been published 469 times since May 10, 2017, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1938 per ML |
|---|---|
| All-time high | $0.2375 (Jul 13, 2022) |
| All-time low | $0.1395 (Apr 17, 2019) |
| 52-week high | $0.1986 |
| 52-week low | $0.1838 |
| Median price | $0.1941 |
| Average price | $0.1940 |
| Largest weekly change | +34.3% (May 22, 2019) |
| Weeks tracked | 469 |
| Tracking since | May 10, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the VITAMIN A, ASCORBIC ACID, CHOLECALCIFEROL, ALPHA-TOCOPHEROL ACETATE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5-PHOSPHATE SODIUM, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, Ferrous sulfate and SODIUM FLUORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Method Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
VITAMIN A, ASCORBIC ACID, CHOLECALCIFEROL, ALPHA-TOCOPHEROL ACETATE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5-PHOSPHATE SODIUM, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, Ferrous sulfate and SODIUM FLUORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Vitamin A class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MULTIVIT-FLUOR-IRON 0.25 MG/ML?
The current National Average Drug Acquisition Cost (NADAC) for MULTIVIT-FLUOR-IRON 0.25 MG/ML, manufactured by Method Pharmaceuticals LLC, is $0.1938 per ML (NDC 58657032750), effective Sep 30, 2026.
How has the price of MULTIVIT-FLUOR-IRON 0.25 MG/ML changed over time?
Over the history we have for it, the NADAC for MULTIVIT-FLUOR-IRON 0.25 MG/ML has held within roughly two percent of its current level. It has been tracked across 469 weekly CMS publications since May 10, 2017.
What are the highest and lowest recorded NADAC prices for MULTIVIT-FLUOR-IRON 0.25 MG/ML?
Since May 10, 2017, the NADAC for MULTIVIT-FLUOR-IRON 0.25 MG/ML has ranged from a low of $0.1395 (Apr 17, 2019) to a high of $0.2375 (Jul 13, 2022), with a median of $0.1941 per ML.
Are there cheaper alternatives to MULTIVIT-FLUOR-IRON 0.25 MG/ML?
No other NADAC-published product currently shares the active ingredient and strength of MULTIVIT-FLUOR-IRON 0.25 MG/ML in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MULTIVIT-FLUOR-IRON 0.25 MG/ML?
MULTIVIT-FLUOR-IRON 0.25 MG/ML (NDC 58657032750) is labeled by Method Pharmaceuticals LLC, and CMS classifies it as a generic product.